Chris P. Recknor - Aug 6, 2021 Form 4 Insider Report for CytoDyn Inc. (CYDY)

Role
Chief Operating Officer
Signature
/s/ Antonio Migliarese, Attorney-in-fact
Stock symbol
CYDY
Transactions as of
Aug 6, 2021
Transactions value $
$0
Form type
4
Date filed
8/10/2021, 06:17 PM
Next filing
Jun 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYDY Common stock Award $0 +19.4K +2.91% $0.00 686K Aug 6, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYDY Non-qualified stock option (right to buy) Award $0 +1.45M $0.00 1.45M Aug 6, 2021 Common stock 1.45M $1.32 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Chris P. Recknor is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents shares received in lieu of 50% of a cash incentive bonus paid for services performed during the fiscal year ended May 31, 2021, which may be paid (a) 100% in cash or (b) 50% in stock and 50% in cash, as determined by the issuer's compensation committee of the board of directors.
F2 The option vests in three equal annual installments beginning on August 6, 2022.